Stay updated with breaking news from Bacteria Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO – Get Rating) in a research note released on Tuesday morning. The firm issued a sell rating on the medical equipment provider’s stock. T2 Biosystems Price Performance Shares of NASDAQ:TTOO opened at $0.47 on Tuesday. The firm has a market capitalization of $3.31 million, a PE […]
15.02.2023 - LEXINGTON, Mass., Feb. 15, 2023 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ: TTOO) today announced the pricing of its previously announced underwritten public offering of 11,111,111 shares of common stock (or common stock equivalents) and ...
28.12.2022 - LEXINGTON, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its Innovative Technology contract with ... Seite 1
20.10.2022 - LEXINGTON, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it has initiated studies to expand the number ... Seite 1
T2 Biosystems, Inc. (NASDAQ:TTOO – Get Rating) CEO John J. Sperzel III purchased 30,000 shares of the stock in a transaction dated Thursday, April 7th. The stock was purchased at an average cost of $0.50 per share, for a total transaction of $15,000.00. Following the completion of the purchase, the chief executive officer now directly […]